Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Laughon

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Maternal Health, Neonatology and Perinatology|August 8, 2019
Correction to: Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic reviewWesley Jackson, Genevieve Taylor, David Selewski, et al.
Maternal Health, Neonatology and Perinatology|November 27, 2018
Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic reviewWesley Jackson, Genevieve Taylor, David Selewski, et al.
American Journal of Perinatology|November 1, 2018
Trial Characteristics That Affect Parental Consent in Neonatal Drug TrialsI Blaire Hanvey, Sofia Aliaga, Matthew M Laughon, et al.
BMC Pediatrics|December 15, 2020
Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety studySimone Schneider, Mary Bailey, Tracy Spears, et al.
American Journal of Perinatology|June 1, 2017
In-Hospital Outcomes Following Extracorporeal Membrane Oxygenation in a Retrospective Cohort of InfantsMaya Schueller, Rachel G Greenberg, P Brian Smith, et al.
Early Human Development|June 22, 2014
Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphaloceleKristin M Corey, Christoph P Hornik, Matthew M Laughon, et al.
The Pediatric Infectious Disease Journal|October 22, 2011
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitisKevin M Watt, Matthew M Massaro, Brian Smith, et al.
Pediatric Pulmonology|August 31, 2018
Risk factors for chronic lung disease and asthma differ among children born extremely pretermWesley M Jackson, Thomas Michael O'Shea, Elizabeth N Allred, et al.
Health and Quality of Life Outcomes|July 28, 2011
Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasiaSara E Massie, Sue Tolleson-Rinehart, Darren A DeWalt, et al.
Early Human Development|September 21, 2015
Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosusBrian C Gulack, Matthew M Laughon, Reese H Clark, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Maternal Health, Neonatology and Perinatology|August 8, 2019
Correction to: Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic reviewWesley Jackson, Genevieve Taylor, David Selewski, et al.
Maternal Health, Neonatology and Perinatology|November 27, 2018
Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic reviewWesley Jackson, Genevieve Taylor, David Selewski, et al.
American Journal of Perinatology|November 1, 2018
Trial Characteristics That Affect Parental Consent in Neonatal Drug TrialsI Blaire Hanvey, Sofia Aliaga, Matthew M Laughon, et al.
BMC Pediatrics|December 15, 2020
Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety studySimone Schneider, Mary Bailey, Tracy Spears, et al.
American Journal of Perinatology|June 1, 2017
In-Hospital Outcomes Following Extracorporeal Membrane Oxygenation in a Retrospective Cohort of InfantsMaya Schueller, Rachel G Greenberg, P Brian Smith, et al.
Early Human Development|June 22, 2014
Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphaloceleKristin M Corey, Christoph P Hornik, Matthew M Laughon, et al.
The Pediatric Infectious Disease Journal|October 22, 2011
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitisKevin M Watt, Matthew M Massaro, Brian Smith, et al.
Pediatric Pulmonology|August 31, 2018
Risk factors for chronic lung disease and asthma differ among children born extremely pretermWesley M Jackson, Thomas Michael O'Shea, Elizabeth N Allred, et al.
Health and Quality of Life Outcomes|July 28, 2011
Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasiaSara E Massie, Sue Tolleson-Rinehart, Darren A DeWalt, et al.
Early Human Development|September 21, 2015
Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosusBrian C Gulack, Matthew M Laughon, Reese H Clark, et al.
Pageof 12